Brookfield Asset Management - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 251 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$2,623,000
-3.7%
44,045
+10.3%
0.01%
-15.4%
Q2 2021$2,723,000
+92.2%
39,923
+95.5%
0.01%
+85.7%
Q1 2021$1,417,000
+28.4%
20,418
+42.1%
0.01%
+40.0%
Q4 2020$1,104,000
+10.1%
14,365
+7.2%
0.01%
-16.7%
Q3 2020$1,003,000
+32.1%
13,406
+11.2%
0.01%
+50.0%
Q2 2020$759,00012,0530.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Prosight Management, LP 139,528$6,083,0004.46%
Eversept Partners, LP 134,151$5,848,9842.68%
DAFNA Capital Management LLC 95,242$4,153,0001.94%
GREAT POINT PARTNERS LLC 302,000$13,167,0001.82%
Atika Capital Management LLC 190,000$8,284,0001.59%
Crawford Lake Capital Management, LLC 205,600$8,964,0001.57%
Crawford Lake Capital Management, LLC 205,688$8,968,0001.57%
Cormorant Asset Management, LP 450,000$19,620,0001.45%
SENZAR ASSET MANAGEMENT, LLC 11,123$485,0001.40%
Rhenman & Partners Asset Management AB 284,621$12,409,0001.27%
View complete list of ARENA PHARMACEUTICALS INC shareholders